MedTrace Logo

Opiate Free Multimodal Pain Pathway in Elective Foot and Ankle Surgery: A Prospective Study

NCT04771741 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2023-04-27

No results posted yet for this study

Summary

Orthopedic surgeons frequently prescribe and over-prescribe narcotic pain medications during the postoperative period, despite the ongoing opioid crisis in the United States. While opioid-free multimodal pathways have shown promising results, there remains a lack of published literature evaluating opiate-free multimodal pain protocols for elective outpatient foot and ankle surgeries. This study aims to evaluate post-operative pain following the use of an opioid-free pain treatment plan for patients undergoing foot and ankle surgeries.

Conditions

  • Bunion of Unspecified Foot
  • Bunionette of Unspecified Foot
  • Hammertoe
  • Ankle Fractures
  • Achilles Tendon Surgery

Interventions

DRUG

Acetominophen

1,000 mg every 6 hours

DRUG

Toradol

10 mg every 6 hours, days 0-3

DRUG

Meloxicam

15 mg once daily, beginning post-op day 4

DRUG

Cyclobenzaprine

10 mg every 8 hours

DRUG

Lyrica

75 mg every 12 hours

Sponsors & Collaborators

  • Prisma Health-Midlands

    lead OTHER

Principal Investigators

  • J. Benjamin Jackson, MD, MBA · Prisma Health-Midlands

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2022-12-31
Completion
2023-04-26
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04771741 on ClinicalTrials.gov